My Next Health Inc. Secures $150 Million Capital Commitment from Global Emerging Markets (GEM)

My Next Health Inc. is pleased to announce it has secured a $150 million equity capital commitment through a share subscription facility entered into with GEM Global Yield LLC SCS a Luxembourg-based private alternative investment group.

Recommended AI News: Seeing Machines unveils its Occula NPU

Under the agreement, GEM has agreed to purchase, for a period of 36 months after a public listing of MNH’s common stock, up to $150 million in shares from time to time upon MNH’s drawdown request. The Company will have no minimum drawdown obligation and will be authorized to utilize the facility on an as-needed basis during the term of the agreement. Subject to certain exceptions, the subscription price for shares to be purchased by GEM under the facility will be based on a 10% discount to the market price of MNH’s shares at such time. In connection with the share subscription facility, on public listing, MNH will issue warrants to GEM to purchase, for a period of three years after a public listing of MNH’s common stock, up to 7.8% of the total equity interests of MNH as of such public listing date at an exercise price equal to the public offering price at the time of MNH’s public listing and subject to a $500M valuation cap. Notwithstanding the foregoing transaction or anything to the contrary herein, there can be no assurance that MNH will achieve a public listing in the near future, or at all.

Recommended AI News: Weber Shandwick Launches Media Security Center to Address Emerging Information Threats

“Securing this capital commitment from the GEM Group propels us forward on the path to improving human health by accelerating the world’s transition to precision medicine,” Chief Executive Officer of MNH, Dr. Richard Heinzl, was quoted. “Working with a strong capital partner like the GEM Group is a valuable support to our business strategy as we look forward to achieving significant corporate objectives in the coming months.”

Recommended AI News: Nervos Integrates with Covalent to Make Accessing Blockchain Data Easier

[To share your insights with us, please write to sghosh@martechseries.com]